Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2
Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, View ORCID ProfileRachel S. Edgar
doi: https://doi.org/10.1101/2021.02.12.21251419
Christine T. Styles
1Department of Infectious Diseases, Imperial College London, St Mary’s Campus, Norfolk Place, London W2 1PG, UK.
Michael Vanden Oever
1Department of Infectious Diseases, Imperial College London, St Mary’s Campus, Norfolk Place, London W2 1PG, UK.
Jonathan Brown
1Department of Infectious Diseases, Imperial College London, St Mary’s Campus, Norfolk Place, London W2 1PG, UK.
Sweta Rai
2Department of Dermatology, King’s College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS.
Sarah Walsh
2Department of Dermatology, King’s College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS.
Finola M. Ryan
3Department of Occupational Health & Wellbeing, Jennie Lee House, King’s College Hospital NHS Foundation Trust, London SE5 8AD, UK.
4Department of Targeted Intervention, University College London, Gower Street, London WC1E 6BT, UK.
Wendy S. Barclay
1Department of Infectious Diseases, Imperial College London, St Mary’s Campus, Norfolk Place, London W2 1PG, UK.
Rachel S. Edgar
1Department of Infectious Diseases, Imperial College London, St Mary’s Campus, Norfolk Place, London W2 1PG, UK.
Article usage
Posted March 11, 2021.
Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2
Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, Rachel S. Edgar
medRxiv 2021.02.12.21251419; doi: https://doi.org/10.1101/2021.02.12.21251419
Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2
Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, Rachel S. Edgar
medRxiv 2021.02.12.21251419; doi: https://doi.org/10.1101/2021.02.12.21251419
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)